| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.36 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |